Nicorandil
EMR200505_506
Approved small_molecule terminated
Quick answer
Nicorandil for Non-obstructive Coronary Artery Disease is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Non-obstructive Coronary Artery Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated